Cancer News and Research

Latest Cancer News and Research

Vitro Diagnostics develops technology and products for cell-based cancer therapy

Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced advances in its adult stem cell products and technology with application to cell-based therapy of cancer. With the passing of Senator Edward Kennedy from brain cancer, we are reminded of such aggressive cancers without effective treatment.

2 Sep 2009

Policymakers need to be educated on the radical difference between radiation therapy and diagnostic testing

Concerned members of the cancer community, including physicians, patient organizations and other care advocates, spoke out today in opposition to a proposed federal policy under consideration by the Centers for Medicare and Medicaid Services (CMS) that would lump life-saving radiation therapy in with diagnostic testing services in receiving major Medicare funding cuts.

2 Sep 2009

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology.

2 Sep 2009

JAMA study reveals the genetic signature of brain cancer

A pair of studies in the July 15 issue of the Journal of the American Medical Association (JAMA) spell out how much closer science has come to unraveling the genetic signature of brain cancer, according to a researcher at the University of Alabama at Birmingham (UAB). Boris Pasche, M.D., Ph.D., director of the UAB Division of Hematology and Oncology, believes these studies represent a new vanguard in the still-changing field of DNA analysis.

2 Sep 2009

Liberal hospice insurance benefits improve health care for patients with advanced illnesses

Patients with advanced illnesses more than doubled their use of hospice care when a major national health plan made hospice care more readily accessible, according to the results of a comparative study published in Journal of Palliative Medicine, a peer-reviewed publication from Mary Ann Liebert, Inc.(www.liebertpub.com).

2 Sep 2009

Weight gain in men linked with risk of prostate cancer

Body mass in younger and older adulthood, and weight gain between these periods of life, may influence a man's risk for prostate cancer. This risk varies among different ethnic populations, according to results of a study in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

2 Sep 2009

Heidelberg neuropathologists detect astrocytomas that can deactivate the "death receptor"

Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy.

2 Sep 2009

White paper stresses the need for healthy living and prevention to be included in healthcare reform

Healthy living and pharmacy Expert and Commentator Marc Isaacson, CEO of Village Green Apothecary, the leading integrative pharmacy in the United States, announced today the release of their white paper, which provides a statistical analysis that explains why healthy living and prevention should be included, if not the focus of Healthcare Reform.

2 Sep 2009

Less-invasive, organ-sparing endoscopic therapy for treating early stages of esophageal cancer

Researchers have found that early stage cancers of the esophagus can be treated as effectively by less-invasive, organ-sparing endoscopic therapy as compared to more complex surgical removal of the esophagus, according to a Mayo Clinic study published in the September 2009 issue of Gastroenterology.

2 Sep 2009

Majority of women depend on family or friend's opinion to decide on breast cancer surgery

About three-quarters of women newly diagnosed with breast cancer have a friend or family member with them at their first visit with a surgeon. And that person plays a significant role in the patient's decision of what type of surgery to have, according to a new study from the University of Michigan Comprehensive Cancer Center.

2 Sep 2009

New research on post-traumatic stress disorder to be presented at MHRF

New research on post-traumatic stress disorder (PTSD) is being presented this week at the Military Health Research Forum (MHRF), a scientific conference hosted by the Department of Defense (DOD) Congressionally Directed Medical Research Programs (CDMRP). Depending on the conflict in which they served, 10 to 30 percent of soldiers who have spent time in war zones experience the debilitating and life-altering symptoms of post-traumatic stress disorder (PTSD).

2 Sep 2009

Hexokinase 2 gene highly expressed in brain metastasis in breast cancer patients

Researchers at the National Cancer Institute have identified a gene that may play a role in breast cancer metastasis to the brain, according to a report in Molecular Cancer Research, a journal of the American Association for Cancer Research.

2 Sep 2009

NF-kappa B inhibitors protect against toxicity during radiation treatment

Directly inhibiting the activity of a key protein mediator of inflammation reduced radiation toxicity in zebrafish embryos, and may ultimately be of help to patients receiving radiation therapy, according to researchers from the Kimmel Cancer Center at Jefferson.

2 Sep 2009

Statistics reveals that blacks experience higher rates of pancreatic cancer deaths than whites

Regardless of risk factors linked to pancreatic cancer, such as smoking and body mass index (BMI), blacks experienced higher rates of pancreatic cancer death than whites.

2 Sep 2009

AICC formed to provide access to the highest quality, integrated care to patients with cancer

A nationwide collection of multi-specialty physician group practices and industry partners have formed an informal coalition aimed at promoting and protecting the fundamental right of patients with cancer to access an integrated and comprehensive program of diagnosis, treatment, comfort and support of the highest quality.

2 Sep 2009

FDA: Earlier methods likely underestimated lead levels in lipsticks

A study by the Food and Drug Administration found lead in lipstick at levels much higher than those detected by the Campaign for Safe Cosmetics (CSC) in a 2007 study that received international attention.

2 Sep 2009

MammoSite ML radiation therapy system approved for breast cancer treatment

Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the U.S. Food and Drug Administration (FDA) cleared the Company's 510K application for the MammoSite((R)) ML radiation therapy system.

1 Sep 2009

Increased risk of ovarian cancer witnessed in women taking hormone therapy

Compared with women who have never taken hormone therapy, those who currently take it or who have taken it in the past are at increased risk of ovarian cancer, regardless of the duration of use, the formulation, estrogen dose, regimen or route of administration, according to a study in the July 15 issue of JAMA.

1 Sep 2009

New computer software capable of sifting through hundreds of cancer causing genetic mutations

Johns Hopkins engineers have devised innovative computer software that can sift through hundreds of genetic mutations and highlight the DNA changes that are most likely to promote cancer.

1 Sep 2009

Telephone counseling and referral service launched for ovarian cancer affected women

Women with ovarian cancer can now find immediate assistance to better cope with their diagnosis by calling 877-OV-HOPE-1 (877-684-6731), a new, free telephone counseling and referral service launched today by a unique partnership: L'Oreal Paris and its charitable partner, the Ovarian Cancer Research Fund (OCRF), and CancerCare, a national non-profit which provides free counseling and education services to individuals and families affected by cancer.

1 Sep 2009

Cancer News and Research

Latest Cancer News and Research

Vitro Diagnostics develops technology and products for cell-based cancer therapy

Policymakers need to be educated on the radical difference between radiation therapy and diagnostic testing

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

JAMA study reveals the genetic signature of brain cancer

Liberal hospice insurance benefits improve health care for patients with advanced illnesses

Weight gain in men linked with risk of prostate cancer

Heidelberg neuropathologists detect astrocytomas that can deactivate the "death receptor"

White paper stresses the need for healthy living and prevention to be included in healthcare reform

Less-invasive, organ-sparing endoscopic therapy for treating early stages of esophageal cancer

Majority of women depend on family or friend's opinion to decide on breast cancer surgery

New research on post-traumatic stress disorder to be presented at MHRF

Hexokinase 2 gene highly expressed in brain metastasis in breast cancer patients

NF-kappa B inhibitors protect against toxicity during radiation treatment

Statistics reveals that blacks experience higher rates of pancreatic cancer deaths than whites

AICC formed to provide access to the highest quality, integrated care to patients with cancer

FDA: Earlier methods likely underestimated lead levels in lipsticks

MammoSite ML radiation therapy system approved for breast cancer treatment

Increased risk of ovarian cancer witnessed in women taking hormone therapy

New computer software capable of sifting through hundreds of cancer causing genetic mutations

Telephone counseling and referral service launched for ovarian cancer affected women

Understanding the DNA Damage Response in Innate Immunity eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in